N/A N=40 Sequential Compression Device on Body Temperature
Hypothermia
Primary: Core Body Temperature — 36.4; 36.3; 35.7; 35.6 degree C
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=310 Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis
Psoriasis
Primary: Percent Change in Psoriasis Area and Severity Index (PASI) From Week 12 to Week 24 — 17.02; 0.86 percent change
Phase 4 N=121 A Randomized Study of Sativex on Cognitive Function and Mood: Multiple Sclerosis Patients
Multiple Sclerosis · Spasticity
Primary: Change From Baseline to the End of Treatment in Paced Auditory Serial Addition Test (PASAT) Total Score. — 6.8; 6.8 units on a scale
N/A N=24 Does Acute Oxytocin Administration Enhance Social Cognition in Individuals With Schizophrenia?
Schizophrenia
Primary: Social Cognition Composite Measure — 0.10; 0.23 Change in z-score
Phase 4 N=157 Phase IV Long-term Maintenance Study of Aripiprazole in the Treatment of Irritability Associated With Autistic Disorder
Irritability Associated With Autistic Disorder
Primary: Percentage of Patients Relapsing by Week 16 — 32; 50 Percentage of participants — p=0.097
Phase 3 N=546 A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
Type 2 Diabetes
Primary: Adjusted Mean Change From Baseline in Hemoglobin A1C (HbA1c) at Week 24 (Last Observation Carried Forward [LOCF]) — -0.30; -0.67; -0.70; -0.84 Percent — p=0.0002
Phase 3 N=622 Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV
Hepatitis B · Polio · Diphtheria
Primary: Number of Participants With Seroprotection After Primary Series Vaccination With DTaP-IPV-Hep B-PRT~T or CombAct Hib™ + Engerix B™ + Oral Polio Vaccine (OPV) — 176; 185…
Early Phase 1 N=48 Users Study Of The Caverject Delivery System
Healthy
Primary: Delivery System Success Rate (DSSR) — 66.67; 66.67; 100.00; 100.00 percentage of participants
Phase 3 N=40 Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure
Anemia · Renal Failure
Primary: Hemoglobin Concentration at 6 Months — 117; 113 g/L
N/A N=100 Low Level Laser Therapy to Reduce Chronic Pain
Chronic Pain
Primary: Number of Participants Whose Self-reported Degree of Pain on the Visual Analog Scale (VAS) in the Neck and Shoulder Area Decreased by 30% or More From Before to After…
N/A N=72 Study of Low Level Laser Therapy for Body Contouring
Body Contouring
Primary: Incidence of the Reduction of at Least 3.0 Inches Off Their Combined Waist-hips-thighs Circumference. — 21; 2 participants
N/A N=639 Evaluation of the HeartWare Left Ventricular Assist Device for the Treatment of Advanced Heart Failure
Chronic Heart Failure
Primary: The Primary Endpoint is Success at 180 Days Which is Defined as Alive on the Originally Implanted HeartWare® LVAD or Transplanted or Explanted for Recovery. Patient Must…
Phase 3 N=801 Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS)
Acute Coronary Syndrome · Percutaneous Coronary Intervention
Primary: Major Bleeding — 11.2; 8.4 Percent probability
Phase 2 N=36 Safety and Efficacy of Sildenafil in Cystic Fibrosis (CF) Lung Disease
Cystic Fibrosis
Primary: Change in Sputum Elastase Activity — -57 micrograms/mL
N/A N=214 Nurse-led Case Management for Diabetes and Cardiovascular Disease Patients With Depression
Depression
Primary: Combined Effect of Intervention on SCL-20, Systolic Blood Pressure, LDL and HbA1c — -1.57 unitless — p=.001